Lithotech Medical

Company Overview

Snapshot

Founded in February 2001, Lithotech Medical operated with 51–200 employees, specializing in invasive medical devices. The company was acquired by Vention Medical in January 2017.

Business overview

Lithotech Medical develops invasive medical devices utilizing Nitinol Alloy (NiTi). The company offers a comprehensive range of OEM services, spanning from initial concept development and design verification to process validation and full-scale mass production. Its products are applied across various medical fields, including urology, cardiovascular, gastroenterology, and other surgical applications, serving the broader health tech and life sciences sector.

Strategic signal

The acquisition of Lithotech Medical by Vention Medical in January 2017 signaled a strategic consolidation within the medical device industry, particularly in the niche of Nitinol-based invasive technologies. This event indicated Vention Medical's interest in expanding its capabilities and product portfolio in advanced medical materials and manufacturing, suggesting a drive towards integrating specialized technologies for broader market reach.

Company Intelligence Q&A

What is Lithotech Medical's primary focus?

Lithotech Medical primarily focuses on developing invasive medical devices based on Nitinol Alloy (NiTi, offering OEM services from concept to mass production.

When was Lithotech Medical founded?

Lithotech Medical was founded in February 2001.

What types of medical applications do Lithotech Medical's products serve?

Lithotech Medical's products have various medical applications, including urology, cardiovascular, gastroenterology, and other surgical medical devices.

What services does Lithotech Medical provide?

Lithotech Medical offers a wide range of OEM services, from early-stage concept development through design verification and process validation to complete mass production.